CDEK
← All organizations

Eyegate Pharmaceuticals, Inc.

For profitWebsite ↗

Also known as: EyeGate

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 1, 2008

Last known activity

Jul 1, 2017

Timeline

1990s

  1. Jun 1, 1998

    Eyegate Pharmaceuticals, Inc.— Founded

2020s

  1. Dec 21, 2020

    Panoptes Pharma— Acquired

Drugs by trial phase (6 distinct, 13 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 1 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (12)

Details

Founded
Waltham, MA, US Jun 1, 1998
Last known activity
Jul 1, 2017